Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Acceptability and safety of thermal ablation for the treatment of precancerous cervical lesions in Honduras.

Sandoval M, Slavkovsky R, Bansil P, Jeronimo J, Lim J, Figueroa J, de Sanjose S.

Trop Med Int Health. 2019 Dec;24(12):1391-1399. doi: 10.1111/tmi.13315. Epub 2019 Nov 21.

2.

Development and application of a framework to estimate health care costs in China: The cervical cancer example.

Liu YJ, Keane A, Simms KT, Lew JB, Shi JF, Mazariego C, Yuill S, Jeronimo J, Qiao YL, Canfell K.

PLoS One. 2019 Oct 1;14(10):e0222760. doi: 10.1371/journal.pone.0222760. eCollection 2019.

3.

[Access to public physical activity programs in Brazil: National Health Survey, 2013].

Ferreira RW, Caputo EL, Häfele CA, Jerônimo JS, Florindo AA, Knuth AG, Silva MCD.

Cad Saude Publica. 2019 Feb 18;35(2):e00008618. doi: 10.1590/0102-311X00008618. Portuguese.

4.
5.

Should Self-Sampling Be an Option for Women in the United States?

Jeronimo J, Perkins RB, Scalici J, Pierce JY.

J Low Genit Tract Dis. 2019 Jan;23(1):54-57. doi: 10.1097/LGT.0000000000000453. No abstract available.

6.

Formal Thought Disorders-Historical Roots.

Jerónimo J, Queirós T, Cheniaux E, Telles-Correia D.

Front Psychiatry. 2018 Nov 9;9:572. doi: 10.3389/fpsyt.2018.00572. eCollection 2018. Review.

7.

Worthy of further consideration: An updated meta-analysis to address the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions.

Randall TC, Sauvaget C, Muwonge R, Trimble EL, Jeronimo J.

Prev Med. 2019 Jan;118:81-91. doi: 10.1016/j.ypmed.2018.10.006. Epub 2018 Oct 17. Review.

PMID:
30342109
8.

Model for Early Detection of Breast Cancer in Low-Resource Areas: The Experience in Peru.

Bain C, Constant TH, Contreras I, Vega AMB, Jeronimo J, Tsu V.

J Glob Oncol. 2018 Sep;4:1-7. doi: 10.1200/JGO.17.00006.

9.

Reply to M. Swanson et al.

Jeronimo J, Temin S, Castle PE, Shastri SS.

J Glob Oncol. 2018 Sep;4:1-2. doi: 10.1200/JGO.17.00049. Epub 2017 Jul 17. No abstract available.

10.

Triage of Women Testing Positive With the careHPV Test on Self-Collected Vaginal Samples for Cervical Cancer Screening in a Low-Resource Setting.

Poli UR, Gowrishankar S, Swain M, Jeronimo J.

J Glob Oncol. 2018 Sep;4:1-7. doi: 10.1200/JGO.2016.008078. Epub 2017 Sep 29.

11.

Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.

Campos NG, Tsu V, Jeronimo J, Regan C, Resch S, Clark A, Sy S, Kim JJ.

Int J Cancer. 2019 Feb 15;144(4):687-696. doi: 10.1002/ijc.31823. Epub 2018 Oct 16.

12.

Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study.

Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, Meyer-Rath G, Jamieson L, Jordaan S, Sharma M, Regan C, Sy S, Liu G, Tsu V, Jeronimo J, Kim JJ.

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):195-205. doi: 10.1097/QAI.0000000000001778.

13.

Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing.

Beylerian EN, Slavkovsky RC, Holme FM, Jeronimo JA.

J Low Genit Tract Dis. 2018 Jul;22(3):219-224. doi: 10.1097/LGT.0000000000000391.

14.

Depth of Cervical Intraepithelial Neoplasia Grade 3 in Peruvian Women: Implications for Therapeutic Depth of Necrosis.

Taxa L, Jeronimo J, Alonzo TA, Gage J, Castle PE, Cremer ML, Felix JC.

J Low Genit Tract Dis. 2018 Jan;22(1):27-30. doi: 10.1097/LGT.0000000000000355.

15.

Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.

Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ.

BMC Cancer. 2017 Nov 25;17(1):791. doi: 10.1186/s12885-017-3786-3.

16.

Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.

Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, Luciani S, Murokora D, Ngoma T, Qiao Y, Quinn M, Sankaranarayanan R, Sasieni P, Schmeler KM, Shastri SS.

J Glob Oncol. 2016 Oct 12;3(5):635-657. doi: 10.1200/JGO.2016.006577. eCollection 2017 Oct.

17.

Barriers and Challenges to Treatment Alternatives for Early-Stage Cervical Cancer in Lower-Resource Settings.

Wu ES, Jeronimo J, Feldman S.

J Glob Oncol. 2017 May 11;3(5):572-582. doi: 10.1200/JGO.2016.007369. eCollection 2017 Oct. Review.

18.

Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.

Campos NG, Tsu V, Jeronimo J, Njama-Meya D, Mvundura M, Kim JJ.

Health Policy Plan. 2017 Dec 1;32(10):1491. doi: 10.1093/heapol/czx076. No abstract available.

19.

Resource-stratified implementation of a community-based breast cancer management programme in Peru.

Duggan C, Dvaladze AL, Tsu V, Jeronimo J, Constant TKH, Romanoff A, Scheel JR, Patel S, Gralow JR, Anderson BO.

Lancet Oncol. 2017 Oct;18(10):e607-e617. doi: 10.1016/S1470-2045(17)30592-2. Review.

PMID:
28971827
20.

Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States.

Wentzensen N, Massad LS, Mayeaux EJ Jr, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, Chelmow D, Choma KK, Darragh TM, Gage JC, Garcia FAR, Guido RS, Jeronimo JA, Liu A, Mathews CA, Mitchell MM, Moscicki AB, Novetsky AP, Papasozomenos T, Perkins RB, Silver MI, Smith KM, Stier EA, Tedeschi CA, Werner CL, Huh WK.

J Low Genit Tract Dis. 2017 Oct;21(4):216-222. doi: 10.1097/LGT.0000000000000322.

PMID:
28953109
21.

Corrigendum to "Implementation of HPV testing in Latin America" [J. Clin. Virol. 76, S1 (2016) S69-S73].

Jeronimo J, Holme F, Slavkovsky R, Camel C.

J Clin Virol. 2017 Oct;95:12. doi: 10.1016/j.jcv.2017.06.005. Epub 2017 Aug 19. No abstract available.

PMID:
28830013
22.

The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries.

Campos NG, Jeronimo J, Tsu V, Castle PE, Mvundura M, Kim JJ.

Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1500-1510. doi: 10.1158/1055-9965.EPI-16-0787. Epub 2017 Jul 14.

23.

Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings.

Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ.

Cancer Med. 2017 Aug;6(8):2008-2014. doi: 10.1002/cam4.1123. Epub 2017 Jul 14.

24.

Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.

Ogilvie G, Nakisige C, Huh WK, Mehrotra R, Franco EL, Jeronimo J.

Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:15-19. doi: 10.1002/ijgo.12187. Review.

PMID:
28691338
25.

Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low- and lower-middle-income countries.

Holme F, Kapambwe S, Nessa A, Basu P, Murillo R, Jeronimo J.

Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:63-68. doi: 10.1002/ijgo.12185.

PMID:
28691331
26.

Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.

Campos NG, Mvundura M, Jeronimo J, Holme F, Vodicka E, Kim JJ.

BMJ Open. 2017 Jun 15;7(6):e015048. doi: 10.1136/bmjopen-2016-015048.

27.

Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.

Campos NG, Tsu V, Jeronimo J, Njama-Meya D, Mvundura M, Kim JJ.

Health Policy Plan. 2017 Sep 1;32(7):956-968. doi: 10.1093/heapol/czw182.

28.

Screening to Prevent Invasive Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.

Castle PE, Jeronimo J, Temin S, Shastri SS.

J Clin Oncol. 2017 Apr 10;35(11):1250-1252. doi: 10.1200/JCO.2016.71.6563. Epub 2017 Jan 30. No abstract available. Erratum in: J Clin Oncol. 2017 Aug 1;35(22):2591.

PMID:
28135111
29.

To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.

Campos NG, Tsu V, Jeronimo J, Mvundura M, Lee K, Kim JJ.

Int J Cancer. 2017 Mar 15;140(6):1293-1305. doi: 10.1002/ijc.30551.

30.

Secondary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline Summary.

Jeronimo J, Castle PE, Temin S, Shastri SS.

J Oncol Pract. 2017 Feb;13(2):129-133. doi: 10.1200/JOP.2016.017889. Epub 2016 Nov 15. No abstract available. Erratum in: J Oncol Pract. 2017 Jul;13(7):466.

PMID:
27845871
31.

Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries.

Denny L, de Sanjose S, Mutebi M, Anderson BO, Kim J, Jeronimo J, Herrero R, Yeates K, Ginsburg O, Sankaranarayanan R.

Lancet. 2017 Feb 25;389(10071):861-870. doi: 10.1016/S0140-6736(16)31795-0. Epub 2016 Nov 1. Review.

PMID:
27814963
32.

Saving the World's Women from Cervical Cancer.

Tsu V, Jerónimo J.

N Engl J Med. 2016 Jun 30;374(26):2509-11. doi: 10.1056/NEJMp1604113. No abstract available.

33.

World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.

Santesso N, Mustafa RA, Schünemann HJ, Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H, Eckert LO, Forhan SE, Franco EL, Gage JC, Garcia F, Herrero R, Jeronimo J, Lu ER, Luciani S, Quek SC, Sankaranarayanan R, Tsu V, Broutet N; Guideline Support Group.

Int J Gynaecol Obstet. 2016 Mar;132(3):252-8. doi: 10.1016/j.ijgo.2015.07.038. Epub 2015 Dec 14.

PMID:
26868062
34.

Implementation of HPV testing in Latin America.

Jeronimo J, Holme F, Slavkovsky R, Camel C.

J Clin Virol. 2016 Mar;76 Suppl 1:S69-S73. doi: 10.1016/j.jcv.2015.11.035. Epub 2015 Nov 28. Review. Erratum in: J Clin Virol. 2017 Oct;95:12.

PMID:
26699418
35.

Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china.

Valdez M, Jeronimo J, Bansil P, Qiao YL, Zhao FH, Chen W, Zhang X, Kang LN, Paul P, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE.

Int J Cancer. 2016 Mar 15;138(6):1453-61. doi: 10.1002/ijc.29877. Epub 2015 Oct 19.

36.

[Physical activity in staff workers at Centers for Psychosocial Care in southern Brazil: temporal trends].

Jerônimo JS, Jardim VM, Kantorski LP, Domingues MR.

Cad Saude Publica. 2014 Dec;30(12):2656-68. doi: 10.1590/0102-311X00049414. Portuguese.

37.

Correspondence to "Evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa".

Jeronimo J, Tsu V.

J Low Genit Tract Dis. 2015 Apr;19(2):e46. doi: 10.1097/LGT.0000000000000082. No abstract available.

PMID:
25811273
38.

Cometary science. Dust measurements in the coma of comet 67P/Churyumov-Gerasimenko inbound to the Sun.

Rotundi A, Sierks H, Della Corte V, Fulle M, Gutierrez PJ, Lara L, Barbieri C, Lamy PL, Rodrigo R, Koschny D, Rickman H, Keller HU, López-Moreno JJ, Accolla M, Agarwal J, A'Hearn MF, Altobelli N, Angrilli F, Barucci MA, Bertaux JL, Bertini I, Bodewits D, Bussoletti E, Colangeli L, Cosi M, Cremonese G, Crifo JF, Da Deppo V, Davidsson B, Debei S, De Cecco M, Esposito F, Ferrari M, Fornasier S, Giovane F, Gustafson B, Green SF, Groussin O, Grün E, Güttler C, Herranz ML, Hviid SF, Ip W, Ivanovski S, Jerónimo JM, Jorda L, Knollenberg J, Kramm R, Kührt E, Küppers M, Lazzarin M, Leese MR, López-Jiménez AC, Lucarelli F, Lowry SC, Marzari F, Epifani EM, McDonnell JA, Mennella V, Michalik H, Molina A, Morales R, Moreno F, Mottola S, Naletto G, Oklay N, Ortiz JL, Palomba E, Palumbo P, Perrin JM, Rodríguez J, Sabau L, Snodgrass C, Sordini R, Thomas N, Tubiana C, Vincent JB, Weissman P, Wenzel KP, Zakharov V, Zarnecki JC.

Science. 2015 Jan 23;347(6220):aaa3905. doi: 10.1126/science.aaa3905.

39.

Performance of Cervical Cancer Screening Techniques in HIV-Infected Women in Uganda.

Bansil P, Lim J, Byamugisha J, Kumakech E, Nakisige C, Jeronimo JA.

J Low Genit Tract Dis. 2015 Jul;19(3):215-9. doi: 10.1097/LGT.0000000000000090.

PMID:
25551591
40.

The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens.

Chen W, Jeronimo J, Zhao FH, Qiao YL, Valdez M, Zhang X, Kang LN, Bansil P, Paul P, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE.

J Clin Virol. 2014 Dec;61(4):553-7. doi: 10.1016/j.jcv.2014.09.018. Epub 2014 Oct 7.

PMID:
25453572
41.

The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer.

Jeronimo J, Bansil P, Valdez M, Kang LN, Zhao FH, Qiao YL, Chen W, Zhang X, Paul P, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE.

J Low Genit Tract Dis. 2015 Jul;19(3):220-3. doi: 10.1097/LGT.0000000000000088.

PMID:
25279978
42.

Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach.

Bansil P, Wittet S, Lim JL, Winkler JL, Paul P, Jeronimo J.

BMC Public Health. 2014 Jun 12;14:596. doi: 10.1186/1471-2458-14-596.

43.

Comparison of depth of necrosis using cryotherapy by gas and number of freeze cycles.

Cremer M, Ditzian L, Winkler JL, Jerónimo J, Singleton J, Franco HV, Maza M, Conlisk E, Gage J, Castle P, Santos C.

J Low Genit Tract Dis. 2015 Jan;19(1):1-6. doi: 10.1097/LGT.0000000000000042.

PMID:
24886871
44.

CareHPV cervical cancer screening demonstration in a rural population of north India.

Labani S, Asthana S, Sodhani P, Gupta S, Bhambhani S, Pooja B, Lim J, Jeronimo J.

Eur J Obstet Gynecol Reprod Biol. 2014 May;176:75-9. doi: 10.1016/j.ejogrb.2014.03.006. Epub 2014 Mar 12.

PMID:
24685404
45.

Optimal positive cutoff points for careHPV testing of clinician- and self-collected specimens in primary cervical cancer screening: an analysis from rural China.

Kang LN, Jeronimo J, Qiao YL, Zhao FH, Chen W, Valdez M, Zhang X, Bansil P, Paul P, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE.

J Clin Microbiol. 2014 Jun;52(6):1954-61. doi: 10.1128/JCM.03432-13. Epub 2014 Mar 26.

46.

Clinical determinants of a positive visual inspection after treatment with acetic acid for cervical cancer screening.

Castle PE, Qiao YL, Zhao FH, Chen W, Valdez M, Zhang X, Kang LN, Bansil P, Paul P, Bai P, Peck R, Li J, Chen F, Jeronimo J.

BJOG. 2014 May;121(6):739-46. doi: 10.1111/1471-0528.12646. Epub 2014 Feb 28.

47.

A prospective study of age trends of high-risk human papillomavirus infection in rural China.

Kang LN, Castle PE, Zhao FH, Jeronimo J, Chen F, Bansil P, Li J, Chen W, Zhang X, Qiao YL.

BMC Infect Dis. 2014 Feb 21;14:96. doi: 10.1186/1471-2334-14-96.

48.

A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer.

Jeronimo J, Bansil P, Lim J, Peck R, Paul P, Amador JJ, Mirembe F, Byamugisha J, Poli UR, Satyanarayana L, Asthana S; START-UP Study Group.

Int J Gynecol Cancer. 2014 Mar;24(3):576-85. doi: 10.1097/IGC.0000000000000084.

49.

Cost-effectiveness analysis of breast cancer control interventions in Peru.

Zelle SG, Vidaurre T, Abugattas JE, Manrique JE, Sarria G, Jeronimo J, Seinfeld JN, Lauer JA, Sepulveda CR, Venegas D, Baltussen R.

PLoS One. 2013 Dec 10;8(12):e82575. doi: 10.1371/journal.pone.0082575. eCollection 2013.

50.

Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.

Paul P, Winkler JL, Bartolini RM, Penny ME, Huong TT, Nga le T, Kumakech E, Mugisha E, Jeronimo J.

Oncologist. 2013;18 Suppl:6-12. doi: 10.1634/theoncologist.18-S2-6.

Supplemental Content

Loading ...
Support Center